Cullen Value Fund Health Care Select Sector SPDR Fund transactions over time
XLV
Health Care Select Sector SPDR Fund historical holders
total: 2
Transactions details
- Total transactions:
- 3
- New positions:
- 2
- Sold out:
- 1
- Held since:
- 2026 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
Jim Cullen has been an institutional investor in Health Care Select Sector SPDR Fund (XLV) since 2024 Q2. According to 2026 Q2 report, Jim Cullen holds 3,270 shares with a market value of roughly $518.82K representing 1.61% of their equity portfolio. The fund/company first acquired XLV in 2024 Q2, initially purchasing 4,173 shares. Jim Cullen later completely sold out the position and reinvested in XLV again in 2026 Q2. Since the initial investment, Cullen Value Fund has made 2 more transactions in this position.
Does Jim Cullen still hold XLV?
Yes, Jim Cullen continues to hold Health Care Select Sector SPDR Fund (XLV). According to their 2026 Q2 report, they maintain a position of 3,270 shares valued at approximately $518.82K, representing 1.61% of their equity portfolio.
When did Jim Cullen first invest in XLV?
Jim Cullen first invested in Health Care Select Sector SPDR Fund (XLV) in 2024 Q2 at the reported quarter-end price of $145.75 per share, acquiring 4,173 shares in their initial purchase.
What is Jim Cullen's average cost basis for XLV?
Based on historical transaction data, Jim Cullen's estimated cost basis for Health Care Select Sector SPDR Fund (XLV) is approximately $158.66 per share. This represents their average reported price* across all buy transactions.
Has Jim Cullen reinvested in XLV after selling?
Yes, Jim Cullen has shown renewed interest in Health Care Select Sector SPDR Fund (XLV). After completely selling their position, they reinitiated an investment in 2026 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $158.66
XLV transactions history by Cullen Value Fund
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
1.61%
|
3,270
|
$158.66
|
$518,818
|
new
|
+1.61%
|
|
2024 Q3
|
0.00%
|
0
|
$145.75
|
|
-100% (-4,173)
|
-2.71%
|
|
2024 Q2
|
2.71%
|
4,173
|
$145.75
|
$608,215
|
new
|
+2.71%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.